257 related articles for article (PubMed ID: 32266469)
1. Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology.
Stepper L; Filser FA; Fischer S; Schaub J; Gorr I; Voges R
Bioprocess Biosyst Eng; 2020 Aug; 43(8):1431-1443. PubMed ID: 32266469
[TBL] [Abstract][Full Text] [Related]
2. Developing an ultra-intensified fed-batch cell culture process with greatly improved performance and productivity.
Xiang S; Zhang J; Yu L; Tian J; Tang W; Tang H; Xu K; Wang X; Cui Y; Ren K; Cao W; Su Y; Zhou W
Biotechnol Bioeng; 2024 Feb; 121(2):696-709. PubMed ID: 37994547
[TBL] [Abstract][Full Text] [Related]
3. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures.
Yongky A; Xu J; Tian J; Oliveira C; Zhao J; McFarland K; Borys MC; Li ZJ
MAbs; 2019; 11(8):1502-1514. PubMed ID: 31379298
[TBL] [Abstract][Full Text] [Related]
4. Process intensification to produce a difficult-to-express therapeutic enzyme by high cell density perfusion or enhanced fed-batch.
Särnlund S; Jiang Y; Chotteau V
Biotechnol Bioeng; 2021 Sep; 118(9):3533-3544. PubMed ID: 33914903
[TBL] [Abstract][Full Text] [Related]
5. Bioreactor productivity and media cost comparison for different intensified cell culture processes.
Xu S; Gavin J; Jiang R; Chen H
Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910
[TBL] [Abstract][Full Text] [Related]
6. Perfusion seed cultures improve biopharmaceutical fed-batch production capacity and product quality.
Yang WC; Lu J; Kwiatkowski C; Yuan H; Kshirsagar R; Ryll T; Huang YM
Biotechnol Prog; 2014; 30(3):616-25. PubMed ID: 24574326
[TBL] [Abstract][Full Text] [Related]
7. Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production.
Tapia F; Vázquez-Ramírez D; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2016 Mar; 100(5):2121-32. PubMed ID: 26758296
[TBL] [Abstract][Full Text] [Related]
8. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
9. Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality.
Schulze M; Lemke J; Pollard D; Wijffels RH; Matuszczyk J; Martens DE
J Biotechnol; 2021 Jul; 335():65-75. PubMed ID: 34090946
[TBL] [Abstract][Full Text] [Related]
10. Rapid intensification of an established CHO cell fed-batch process.
Schulze M; Niemann J; Wijffels RH; Matuszczyk J; Martens DE
Biotechnol Prog; 2022 Jan; 38(1):e3213. PubMed ID: 34542245
[TBL] [Abstract][Full Text] [Related]
11. "Organized stress" for robust scale-up of intensified production process with fed-batch seed bioreactor.
Ben Yahia B; Piednoir A; Dahomais T; Eggermont S; Paul W
Biotechnol Bioeng; 2023 Sep; 120(9):2509-2522. PubMed ID: 37027375
[TBL] [Abstract][Full Text] [Related]
12. Principles and approach to developing mammalian cell culture media for high cell density perfusion process leveraging established fed-batch media.
Lin H; Leighty RW; Godfrey S; Wang SB
Biotechnol Prog; 2017 Jul; 33(4):891-901. PubMed ID: 28371394
[TBL] [Abstract][Full Text] [Related]
13. Process intensification for the production of rituximab by an inducible CHO cell line.
Mellahi K; Brochu D; Gilbert M; Perrier M; Ansorge S; Durocher Y; Henry O
Bioprocess Biosyst Eng; 2019 May; 42(5):711-725. PubMed ID: 30673843
[TBL] [Abstract][Full Text] [Related]
14. Repurposing fed-batch media and feeds for highly productive CHO perfusion processes.
Kuiper M; Spencer C; Fäldt E; Vuillemez A; Holmes W; Samuelsson T; Gruber D; Castan A
Biotechnol Prog; 2019 Jul; 35(4):e2821. PubMed ID: 30985083
[TBL] [Abstract][Full Text] [Related]
15. Cell-controlled hybrid perfusion fed-batch CHO cell process provides significant productivity improvement over conventional fed-batch cultures.
Hiller GW; Ovalle AM; Gagnon MP; Curran ML; Wang W
Biotechnol Bioeng; 2017 Jul; 114(7):1438-1447. PubMed ID: 28128436
[TBL] [Abstract][Full Text] [Related]
16. Bax and Bak knockout apoptosis-resistant Chinese hamster ovary cell lines significantly improve culture viability and titer in intensified fed-batch culture process.
Tang D; Lam C; Bauer N; Auslaender S; Snedecor B; Laird MW; Misaghi S
Biotechnol Prog; 2022 Mar; 38(2):e3228. PubMed ID: 34951158
[TBL] [Abstract][Full Text] [Related]
17. Fed-batch performance profiles for mAb production using different intensified N - 1 seed strategies are CHO cell-line dependent.
Tang Y; Xu J; Xu M; Huang Z; Santos J; He Q; Borys M; Khetan A
Biotechnol Prog; 2024 Feb; ():e3446. PubMed ID: 38415506
[TBL] [Abstract][Full Text] [Related]
18. Exploring the limits of conventional small-scale CHO fed-batch for accelerated on demand monoclonal antibody production.
Mahé A; Martiné A; Fagète S; Girod PA
Bioprocess Biosyst Eng; 2022 Feb; 45(2):297-307. PubMed ID: 34750672
[TBL] [Abstract][Full Text] [Related]
19. Perfusion Cell Culture Decreases Process and Product Heterogeneity in a Head-to-Head Comparison With Fed-Batch.
Walther J; Lu J; Hollenbach M; Yu M; Hwang C; McLarty J; Brower K
Biotechnol J; 2019 Feb; 14(2):e1700733. PubMed ID: 29851298
[TBL] [Abstract][Full Text] [Related]
20. Orbitally Shaken Single-Use Bioreactor for Animal Cell Cultivation: Fed-Batch and Perfusion Mode.
Bürgin T; Coronel J; Hagens G; Keebler MV; Genzel Y; Reichl U; Anderlei T
Methods Mol Biol; 2020; 2095():105-123. PubMed ID: 31858465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
